Loading clinical trials...

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors | Clinical Trials | Clareo Health

Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Prevalence of Synovitis in Patients With Haemophilia A

Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo

A Study to Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Dosage and PD Study of Eftrenonacog-alfa

Trial snapshot

Condition

Locations shown

For caregivers